SCHEMBL686923

SCHEMBL686923

O=C(O)C[C@H](NC(=O)Nc1cccn(Cc2cccs2)c1=O)c1ccc(F)c(C(F)(F)F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.38
KDM4E B2RXH2 7/20 0.38
LMNA P02545 3/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PTGER3 P43115 6/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
POLB P06746 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
ITGB1 P05556 3/20 0.35
ITGA4 P13612 3/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688850 0.88 PTGER3 (0.41) ALDH1A1KDM4ELMNAHPGDMEN1
SCHEMBL688383 0.87 ALDH1A1 (0.46) ALDH1A1KDM4ELMNAHPGDMEN1
SCHEMBL688594 0.87 PTGER3 (0.47) ALDH1A1KDM4ELMNAHPGDMEN1
SCHEMBL687576 0.86 ALDH1A1 (0.48) ALDH1A1KDM4ELMNAHPGDMEN1
SCHEMBL687831 0.84 ALDH1A1 (0.45) ALDH1A1KDM4ELMNAHPGDMEN1
SCHEMBL686959 0.84 PTGER3 (0.58) ALDH1A1KDM4ELMNAHPGDMEN1
SCHEMBL687917 0.83 KDM4E (0.47) ALDH1A1KDM4ELMNAHPGDMEN1
SCHEMBL686746 0.82 CYP26A1 (0.40) ALDH1A1KDM4ELMNAHPGDMEN1
SCHEMBL687812 0.82 POLB (0.45) LMNAHPGDSMN1; SMN2MAPTRAB9A
SCHEMBL687894 0.82 HDAC3 (0.37) ALDH1A1KDM4ELMNAHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1176956-B1 CARBOXYLIC ACID DERIVATIVES THAT INHIBIT THE BINDING OF INTEGRINS TO THEIR RECEPTORS ENCYSIVE PHARMACEUTICALS INC (US) 2008-01-09 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed